Acurx Pharmaceuticals Enhances Brand Recognition with FDA and USPTO Approvals for Ibezapolstat#United_States#Ibezapolstat#Staten_Island#Acurx_Pharmaceuticals#CIFBEZY
Acurx Pharmaceuticals Enhances Brand Recognition with FDA and USPTO Approvals for Ibezapolstat
Acurx Pharmaceuticals has received FDA conditional acceptance and USPTO trademark allowance for its leading antibiotic candidate, Ibezapolstat, which marks significant progress in its commercialization journey.
third-news.com
August 17, 2026 at 12:07 PM
Acurx Pharmaceuticals Enhances Brand Recognition with FDA and USPTO Approvals for Ibezapolstat#United_States#Ibezapolstat#Staten_Island#Acurx_Pharmaceuticals#CIFBEZY
#ACXP Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
https://www.stocktitan.net/news/ACXP/acurx-pharmaceuticals-receives-fda-conditional-acceptance-and-uspto-9mhh6umc091f.html
https://www.stocktitan.net/news/ACXP/acurx-pharmaceuticals-receives-fda-conditional-acceptance-and-uspto-9mhh6umc091f.html
Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
The proposed proprietary name, or brand name, CIFBEZY has received conditional acceptance from the FDA and also federal trademark allowance from the USPTO These initial milestones will form the basis for the commercial identity of Acurx's lead product candidate, ibezapolstat, as the Company prepares to advance it toward its international Phase 3...
www.stocktitan.net
August 17, 2026 at 12:01 PM
#ACXP Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
https://www.stocktitan.net/news/ACXP/acurx-pharmaceuticals-receives-fda-conditional-acceptance-and-uspto-9mhh6umc091f.html
https://www.stocktitan.net/news/ACXP/acurx-pharmaceuticals-receives-fda-conditional-acceptance-and-uspto-9mhh6umc091f.html